Thanks for accessing our exclusive report on diversifying your portfolio. You'll shortly receive an email with a link to the report - happy reading!
As Myocarditis Debate Rages On, Heart Disease Cases Mount
Few had heard of myocarditis before the pandemic, but now it’s a serious worry making global headlines. One company is hoping to treat it.
What is the Future of Streaming Services?
As Netflix (NASDAQ: NFLX) subscribers dwindle, the streaming giant embraces advertising. Here we consider the outlook for this, and several other,...
IPO Outlook: MAIA, MGAM
In this week's preview of upcoming IPOs we take a look at MAIA Biotechnology and Mobile Global Esports.
INFY, PII, OTIS, VLO, BAH: Earnings Preview
Earnings due this week include Infosys (NYSE: INFY), Polaris (NYSE: PII), Otis Worldwide (NYSE: OTIS), Valero (NYSE: VLO), Booz Allen Hamilton...
Is Legend Biotech Stock a Solid Investment?
With major backing and a promising lead product candidate, Legend Biotech stock looks like an exciting investment opportunity. But is this life...
Patients Welcome Relief from Particle Pollution Harm
Poor air quality, in part caused by issues surrounding climate change, has forced these healthcare companies into looking at ways to combat heart...
What is Life Sciences and Should You Invest?
Investment in Life Sciences has exploded in recent years. But what is Life Sciences? Read on to discover the nature-based opportunities in this field.
IPO Outlook: VRAX, JZ
In this week's preview of upcoming IPOs we take a look at Virax Biolabs Group and Jianzhi Education Technology Group.